Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
As of March 31, 2025 • 4:51 PM ET
As of March 31, 2025 • 4:51 PM ET
Date/Time | Source | News Release |
---|---|---|
02/10/2025 05:19 PM EST | SeekingAlpha | iBio GAAP EPS of -$0.48 |
01/31/2025 05:25 PM EST | SeekingAlpha | iBio files for secondary offering |
01/02/2025 07:04 AM EST | SeekingAlpha | iBio expands cardiometabolic and obesity program |
11/12/2024 06:13 PM EST | SeekingAlpha | iBio GAAP EPS of -$0.46 in-line |
11/10/2024 08:01 AM EST | SeekingAlpha | Earnings week ahead: DIS, BABA, JD, CSCO, HD, OXY, SU, SHOP, AMAT, SPOT, and more |
09/20/2024 04:19 PM EDT | SeekingAlpha | iBio GAAP EPS of -$4.03, revenue of $0.23M beats by $0.2M |
07/05/2024 08:10 AM EDT | SeekingAlpha | iBio files $150M mixed shelf offering |
05/28/2024 07:30 AM EDT | KlickAnalytics | Buy Recommendation Issued On IBIO By Chardan Capital |
05/13/2024 05:12 PM EDT | SeekingAlpha | iBio reports Q3 results |
04/16/2024 04:20 PM EDT | SeekingAlpha | iBio files to sell 10.57M shares of common stock for holders |
Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.